SEVERE WX : Winter Weather Advisory View Alerts
CLOSINGS: View Closings

Some EpiPen expiration dates get extended on heels of shortage

The US Food and D...

Posted: Aug 21, 2018 6:01 PM
Updated: Aug 21, 2018 6:01 PM

The US Food and Drug Administration announced Tuesday that it is extending the expiration date for certain EpiPens.

EpiPens are auto-injectors that deliver epinephrine to help treat life-threatening allergic reactions. The expiration extension comes in response to an ongoing shortage of the medications, which were added to the FDA's drug shortage list in May.


Business and industry sectors

Business, economy and trade

Diseases and disorders

Drug safety, efficacy and availability

Drug shortages

Government organizations - US

Health and medical

Pharmaceutical industry

Pharmaceuticals and biotechnology

Pharmaceuticals and prescription drugs

US Department of Health and Human Services

US federal departments and agencies

US Food and Drug Administration

"We are doing everything we can to help mitigate shortages of these products, especially ahead of the back-to-school season," Dr. Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, said in a written statement.

"We've completed the necessary reviews of the data to extend the expiration date by four months for specific lots of EpiPen that are expired or close to expiring. We're hopeful this action will ensure patients have access to this important medication and provide additional peace-of-mind to parents as the agency works with the manufacturer to increase supply," she said.

The extension, which goes beyond the approved 20-month shelf life, applies to specific lots of EpiPen 0.3-milligram auto-injectors and the authorized generic version that have expiration dates between April 2018 and December 2018, according to a statement from pharmaceutical company Pfizer.

Meridian, a subsidiary of Pfizer, manufactures EpiPen, EpiPen Jr. and the authorized generic versions of those products for the pharmaceutical company Mylan.

"There have been recent concerns about shortages of EpiPens, which has been especially an issue as families are refilling prescriptions for back-to-school planning," Dr. Robert Wood, president of the American Academy of Allergy, Asthma & Immunology and director of pediatric allergy and immunology at Johns Hopkins Medicine in Baltimore, told CNN last week.

Multiple factors, including regional supply disruptions and manufacturer issues, have contributed to limited availability in certain regions, according to the FDA.

In its statement, the FDA noted that it has continued working closely with Mylan on production and supply, and has been in contact with manufacturers of other epinephrine auto-injectors, such as Adrenaclick and Auvi-Q.

The FDA also announced last week that it has approved the first generic version of EpiPen, which will be available in the coming months.

Article Comments

Mason City
57° wxIcon
Hi: 64° Lo: 30°
Feels Like: 57°
Albert Lea
57° wxIcon
Hi: 61° Lo: 27°
Feels Like: 57°
57° wxIcon
Hi: 64° Lo: 32°
Feels Like: 57°
Charles City
57° wxIcon
Hi: 63° Lo: 36°
Feels Like: 57°
55° wxIcon
Hi: 61° Lo: 33°
Feels Like: 55°
Scattered showers on Thursday
KIMT Radar
KIMT Eye in the sky

Latest Video


Impact of Stockpiling Groceries


Shortage of Protective Personal Equipment


What to Look For in Disinfectants and Sanitizers


Avoid Cyber Attacks While Working from Home


Chris' PM Weather Forecast 4/2


Coronavirus Testing


IBM employees in Rochester helping fight COVID-19


Coronavirus impacting elections this fall


Custody arrangements during a pandemic


Sara's Midday Forecast - Thursday

Community Events